CVS completes first round of COVID-19 vaccination at 8,000 U.S. nursing homes
Drugstore chain CVS Health Corp said on Monday it has completed administering the first round of COVID-19 vaccination at about 8,000 U.S. nursing facilities.
Related Articles
India’s Biocon developing its own version of Wegovy, clinical trial likely next year
Indian drugmaker Biocon , looking to grab a piece of the exploding weight-loss drug market as early as possible, is developing its own version of…
Weight-loss drug developer Metsera raises $290 million in funding
Weight-loss drug developer Metsera has raised $290 million in funding, led by biotech investor ARCH Venture Partners as well as participation from firms such as…
Cerevel’s Parkinson’s disease drug improves symptom control in late-stage trial
Cerevel Therapeutics said its Parkinson’s disease drug improved symptom control in patients when tested as an add-on therapy, meeting the main goal in a late-stage…
Elevance’s higher premiums keep costs under control, boost quarterly profit
Elevance Health on Thursday reported quarterly profit above Wall Street estimates and slightly raised its annual earnings forecast, as higher premiums from commercial insurance plans…
UnitedHealth unit Change Healthcare faces issue processing some medical claims
UnitedHealth Group said on Thursday a service provided by its Change Healthcare unit was facing an issue receiving batches of medical claims from customers.
German watchdog approves Novo’s acquisition of Cardior Pharmaceuticals
The German cartel office has approved a deal by Denmark’s Novo Nordisk to purchase Cardior Pharmaceuticals, the regulator said in a statement on Thursday.
Weight-loss drug developer Metsera raises $290 million in funding
Weight-loss drug developer Metsera has raised $290 million in funding, led by biotech investor ARCH Venture Partners as well as participation from firms such as…
Cerevel Therapeutics’ Parkinson’s disease drug meets main goal in late-stage study
Cerevel Therapeutics said on Thursday its Parkinson’s disease drug met the main goal of a late-stage trial.
Elevance beats first-quarter profit estimates on higher premiums
Elevance Health beat Wall Street estimates for first-quarter profit on Thursday, as higher premiums in its commercial insurance business helped keep medical costs for the…
German watchdog approves Novo’s acquisition of Cardior Pharmaceuticals
The German cartel office has approved a deal by Denmark’s Novo Nordisk to purchase Cardior Pharmaceuticals, the regulator said in a statement on Thursday.